Form 4: P&G SVP Janzaruk Reports Stock Option Grant
Insider Transaction Report
Procter & Gamble's SVP and Chief Accounting Officer, Matthew W. Janzaruk, reported the acquisition of 13,779 stock options and adjustments to common stock holdings.
Summary
- Matthew W. Janzaruk, SVP Chief Accounting Officer of Procter & Gamble Co (PG), filed a Form 4 detailing changes in his beneficial ownership.
- The filing reports the acquisition of 13,779 stock options with an exercise price of $153.18, granted on October 1, 2025.
- These stock options become exercisable on September 29, 2028, and have an expiration date of October 1, 2035.
- Janzaruk's direct beneficial ownership of common stock is 1,703.9031 shares.
- Indirect beneficial ownership of common stock through a retirement plan trustee is 3,293.5342 shares, reflecting an adjustment through September 30, 2025.
- The reported transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.
Sentiment
Score: 7
Explanation: The grant of stock options to a key executive is a positive event, aligning management incentives with shareholder interests. It's a routine compensation disclosure and reflects standard corporate governance practices.
Positives
- The grant of 13,779 stock options to a key executive like the SVP Chief Accounting Officer aligns management incentives with long-term shareholder value creation.
- The transaction was executed under a Rule 10b5-1(c) plan, demonstrating a structured and compliant approach to executive equity compensation.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy | The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan to comply with insider trading regulations. | 10/01/2025 | Enhances transparency and reduces the risk of insider trading allegations by establishing a pre-planned schedule for equity transactions, reflecting sound corporate governance. |
Stakeholder Impact
- Shareholders: The grant of stock options aligns the interests of a key executive with long-term shareholder value creation, potentially fostering better performance.
- Employees: This filing primarily concerns executive compensation and does not directly impact the broader employee base.
Key Dates
| Date | Description |
|---|---|
| 10/01/2025 | Date of earliest transaction (stock option grant and common stock adjustment) |
| 10/02/2025 | Signature date of the Form 4 filing |
| 09/29/2028 | Date stock options become exercisable |
| 10/01/2035 | Stock option expiration date |
Recommendation
holdThis Form 4 reports a routine executive compensation event (stock option grant) and does not provide new information that would fundamentally alter the investment thesis for Procter & Gamble. While it aligns executive incentives, it is not a direct indicator for a 'buy' or 'sell' decision based solely on this filing.
Keywords
Procter & Gamble, PG, Form 4, insider transaction, stock options, executive compensation, Matthew W. Janzaruk, Chief Accounting Officer, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.